COVID-19 and the impact on the incidence and treatment of acute stroke in France


  • At least in the Alsace region of France, the COVID-19 outbreak did not alter the incidence of stroke, but those admitted/seeking medical attention during the therapeutic window was reduced.

Why this matters

  • Timely access to treatment during the known therapeutic window is paramount to ensure the most positive patient outcomes are achieved.

  • Public awareness regarding the need for early health-seeking behavior, irrespective of the COVID-19 outbreak, needs to be increased.